CASE STUDY #2

Pivotal Phase III trial undergoes audits by the FDA and sponsor

CASE STUDY #3

ARG successfully starts up a Phase II trial within 6 weeks

CASE STUDY #4

ARG rescues Phase I oncology trial using TrialVista® CTMS

CASE STUDY #5

Preferred Provider Status for Atlantic Research Group